Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
4,185
Total Claims
$288K
Drug Cost
344
Beneficiaries
$838
Cost/Patient
Risk Score Breakdown 8/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+30%
Opioid rate vs peers
2.9% vs 2.2% avg
-41%
Cost per patient vs peers
$838 vs $1,411 avg
-3%
Brand preference vs peers
10.3% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.9%
Opioid Rate
122
Opioid Claims
$1,207
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 424 claims · $201K
Generic: 3,701 claims · $85K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 34 | $32K |
| Apixaban | 25 | $19K |
| Semaglutide | 14 | $16K |
| Lipase/Protease/Amylase | 14 | $15K |
| Fluticasone Propion/Salmeterol | 11 | $4,912 |
| Atorvastatin Calcium | 226 | $4,610 |
| Levothyroxine Sodium | 230 | $4,074 |
| Rosuvastatin Calcium | 49 | $3,272 |
| Gabapentin | 96 | $2,655 |
| Losartan Potassium | 119 | $2,246 |
| Omeprazole | 106 | $2,245 |
| Lidocaine | 21 | $2,199 |
| Metoprolol Succinate | 97 | $2,142 |
| Mirtazapine | 45 | $2,129 |
| Pantoprazole Sodium | 89 | $1,677 |
Prescribing Profile
Patient Profile
71
Avg Age
73%
Female
1.20
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About